EASSI - Evaluation of the Safety of Self-Administration With Icatibant

PHASE3CompletedINTERVENTIONAL
Enrollment

151

Participants

Timeline

Start Date

September 25, 2009

Primary Completion Date

June 22, 2011

Study Completion Date

June 22, 2011

Conditions
Hereditary Angioedema
Interventions
DRUG

Icatibant

Single subcutaneous injection of icatibant, 30 mg

Trial Locations (26)

8036

Universitätsklinik für Dermatologie und Venerologie, Graz

8091

Universitätsspital Zürich / Dermatologische Klinik, Zurich

10117

Universitätsmedizin Berlin, Klinik für Dermatologie, Venerologie und Allergologie, Charité, Berlin

20157

Ospedale Luigi Sacco, Milan

28007

Hospital General Universitario Gregorio Maranon, Madrid

28046

Hospital Universitario La Paz, Servicio de Alergia, Madrid

31048

Bnai-Zion M.C. Clinical Immunology and Allergy Division, Haifa

38043

Clinique Universitaire de Medicine/ Centre National de reference, Grenoble

45127

Universitäts-Hals-Nasen-Ohren-Klinik Essen, Universität Duisburg-Essen, Essen

46009

Hospital Universitario La Fe, Servicio de Alergia, Valencia

49933

Centre Hospitalier Universitaire/ Service de Dermatologie, Angers

52621

The Chaim Sheba Medical Center, The Allergy and Clinical Immunology Unit, Tel Litwinsky

55101

Hautklinik und Poliklinik, Universitätsmedizin der Johannes Gutenberg-Universität, Mainz

59037

Hopital Claude Huriex/ Service de medicine interne, Lille

60590

Klinkum der Johann Wolfgang Goethe-Universitat, Frankfurt am Main

64239

Tel Aviv Sourasky Medical Center - Allergy Unit, Tel Aviv

69437

Hospital Edouaed Herriot, Lyon

75015

Hopital Europeen Georges Pompidou Immunologie Clinique, Paris

80131

Universita degli Studi di Napoli 'Federico II', Napoli

C1035AAT

Hospital Britanico Unidad de Alergia, Buenos Aires

Unknown

Odense Universitetshospital-OUH, Odense

Luzerner Kantonsspital, Lucerne

08035

Hospital Universitario Vall de Hebrón / Sección de Alergia, Escola Infermeria, Barcelona

BS10 5NB

Southmead Hospital, Department of Immunology, Bristol

E1 2ES

Barts & The London NHS Trust, Pathology and Pharmacy Building, London

PL6 8DH

Derriford Combined Laboratory, Department of Clinical Immunology & Allergy, Plymouth

Sponsors

Lead Sponsor

Collaborators (1)

All Listed Sponsors
collaborator

Jerini AG

INDUSTRY

lead

Shire

INDUSTRY

NCT00997204 - EASSI - Evaluation of the Safety of Self-Administration With Icatibant | Biotech Hunter | Biotech Hunter